| Name | Title | Contact Details |
|---|---|---|
Brian Matross |
Senior Counsel | Profile |
Jonathan Turner |
Chief Ethics & Compliance Officer | Profile |
Jen Izzo |
Assistant General Counsel | Profile |
Vinita Sinha |
General Counsel, Cardiac Management Solutions Division | Profile |
Gauri Dhavan |
Chief Intellectual Property Counsel | Profile |
BeFutur Biotechnologies is a Montreal, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Specialty Medical Equipment is a Norwood, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PreXion is a San Mateo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.
Wasatch Microfluidics is a North Salt Lake, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.